P0719 Epidemiology of Pediatric Ibd in the Greater Toronto Area

Walters, Thomas D.; Critch, Jeff; Kundhal, Pavi S.; Sherman, Philip M.; Griffiths, Anne M.

doi:10.1097/00005176-200406001-00843

Cited by 5 publications

(10 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean age at IBD diagnosis was 14.7 years (median 15, range 4-18), whereas the mean age at diagnosis of CD was 15.1 years (median 16.5, range [4][5][6][7][8][9][10][11][12][13][14][15][16][17][18], that of UC was 14.2 years (median 14, range [8][9][10][11][12][13][14][15][16][17][18], and that of IC was 14.1 years (median 14.5, range 6-17) (Fig. 2).…”

Section: Resultsmentioning

confidence: 99%

Epidemiology of Pediatric Chronic Inflammatory Bowel Disease in Central and Western Slovenia, 1994–2005

Orel

Kamhi

Vidmar

et al. 2009

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Epidemiology of Pediatric Chronic Inflammatory Bowel Disease in Central and Western Slovenia, 1994–2005

Orel

Kamhi

Vidmar

et al. 2009

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

show abstract

“…1 In addition, one Canadian study has also shown that the average age at diagnosis of CD in children is falling. 2 Children with CD commonly have nutritional complications at diagnosis including weight loss, impaired linear growth or specific nutritional deficiencies. 3,4 None of the therapies currently available for the management of CD are curative.…”

Section: Introductionmentioning

confidence: 99%

“…Over recent years the incidence of CD in children has increased 1 . In addition, one Canadian study has also shown that the average age at diagnosis of CD in children is falling 2 . Children with CD commonly have nutritional complications at diagnosis including weight loss, impaired linear growth or specific nutritional deficiencies 3,4 …”

Section: Introductionmentioning

confidence: 99%

International survey of enteral nutrition protocols used in children with Crohn's disease

Whitten¹,

Rogers

Ooi

et al. 2012

J of Digest Diseases

View full text Add to dashboard Cite

OBJECTIVE: Differing protocols have been utilized in published studies evaluating exclusive enteral nutrition (EEN) in the management of active pediatric Crohn's disease. This study aimed to ascertain the protocols currently utilized in different pediatric centers around the world and to highlight their similarities and differences. METHODS: A questionnaire was circulated to individuals at pediatric centers in countries in Europe, North America and Asia–Pacific. Respondents were asked to indicate the number of children treated with EEN at their centers in the previous years and to provide details of their protocol used for administering EEN to these children. RESULTS: Responses were received from 35 separate centers (42% of those asked). The duration of EEN varied from <6 weeks to >12 weeks, but was most commonly 6 to 8 weeks. Although 23 different formulas were utilized across the centers, most (90%) used polymeric formulas. Flavourings were commonly added to formulas but wide variations existed between centers with the prescription of food and fluids permitted during the EEN period. The reintroduction of food after EEN also varied greatly: the most common recommendations were for an initial low‐fiber diet (26%) or the gradual introduction of food quantity as the formula volume decreased (52%). CONCLUSIONS: This questionnaire‐based study has shown the wide variations in EEN protocols used in different areas of the world. The development of consistent protocols may enhance the acceptance, efficacy and wider utilization of this therapy.

show abstract

“…Inflammatory bowel disease (IBD) is becoming increasingly common in developed countries worldwide. Recent epidemiological data suggest increasing incidence of IBD along with falling age at presentation 1–3. IBD may be diagnosed throughout childhood, with peak incidence in the teenage years.…”

mentioning

confidence: 99%

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

Sidler

Leach

Day

2008

Inflammatory Bowel Diseases

135

146

View full text Add to dashboard Cite

Both fecal markers were superior to the sensitivities and specificities of any standard inflammatory test. Both fecal S100A12 and calprotectin are sensitive markers of gastrointestinal inflammation, but fecal S100A12 provided exceptional specificity in distinguishing children with IBD from children without IBD. Fecal S100A12 is a simple, noninvasive test that can be used to screen and select children warranting further invasive and laborious procedures such as endoscopy for the investigation of their gastrointestinal symptoms.

show abstract

P0719 Epidemiology of Pediatric Ibd in the Greater Toronto Area

Cited by 5 publications

References 0 publications

Epidemiology of Pediatric Chronic Inflammatory Bowel Disease in Central and Western Slovenia, 1994–2005

Epidemiology of Pediatric Chronic Inflammatory Bowel Disease in Central and Western Slovenia, 1994–2005

International survey of enteral nutrition protocols used in children with Crohn's disease

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

Contact Info

Product

Resources

About